Horrell Capital Management Inc. Buys 597 Shares of Encompass Health Corporation $EHC

Horrell Capital Management Inc. boosted its position in Encompass Health Corporation (NYSE:EHC) by 2.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 27,427 shares of the company’s stock after purchasing an additional 597 shares during the quarter. Encompass Health comprises 1.4% of Horrell Capital Management Inc.’s investment portfolio, making the stock its 22nd biggest position. Horrell Capital Management Inc.’s holdings in Encompass Health were worth $3,363,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in EHC. Pinnacle Wealth Planning Services Inc. increased its stake in Encompass Health by 4.0% in the first quarter. Pinnacle Wealth Planning Services Inc. now owns 2,597 shares of the company’s stock valued at $263,000 after acquiring an additional 99 shares during the last quarter. Securian Asset Management Inc. increased its holdings in Encompass Health by 1.3% during the 2nd quarter. Securian Asset Management Inc. now owns 7,716 shares of the company’s stock valued at $946,000 after purchasing an additional 100 shares during the period. State of Michigan Retirement System raised its holdings in shares of Encompass Health by 0.4% during the second quarter. State of Michigan Retirement System now owns 24,245 shares of the company’s stock valued at $2,973,000 after acquiring an additional 100 shares in the last quarter. Caitong International Asset Management Co. Ltd lifted its position in shares of Encompass Health by 19.0% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 720 shares of the company’s stock worth $73,000 after purchasing an additional 115 shares during the period. Finally, UMB Bank n.a. grew its holdings in shares of Encompass Health by 10.9% during the 2nd quarter. UMB Bank n.a. now owns 1,187 shares of the company’s stock worth $146,000 after acquiring an additional 117 shares during the period. 97.25% of the stock is currently owned by hedge funds and other institutional investors.

Encompass Health Trading Up 0.4%

Shares of NYSE:EHC opened at $115.62 on Wednesday. The stock’s 50-day simple moving average is $123.25 and its two-hundred day simple moving average is $119.75. The stock has a market capitalization of $11.63 billion, a price-to-earnings ratio of 21.86, a PEG ratio of 2.20 and a beta of 0.91. Encompass Health Corporation has a 52-week low of $87.85 and a 52-week high of $127.99. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.06 and a current ratio of 1.06.

Encompass Health (NYSE:EHC) last issued its quarterly earnings data on Wednesday, March 16th. The company reported $0.93 earnings per share for the quarter. The firm had revenue of $136.30 million for the quarter. Encompass Health had a net margin of 9.33% and a return on equity of 18.19%. Encompass Health has set its FY22 guidance at $3.83-$4.19 EPS. Analysts expect that Encompass Health Corporation will post 4.8 EPS for the current year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, January 15th. Stockholders of record on Friday, January 2nd will be given a dividend of $0.19 per share. The ex-dividend date of this dividend is Friday, January 2nd. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. Encompass Health’s payout ratio is presently 14.37%.

Analysts Set New Price Targets

Several equities research analysts recently commented on the stock. Zacks Research raised shares of Encompass Health from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, October 21st. UBS Group raised their price target on Encompass Health from $140.00 to $150.00 and gave the company a “buy” rating in a report on Thursday, October 2nd. KeyCorp raised their price objective on shares of Encompass Health from $135.00 to $140.00 and gave the company an “overweight” rating in a research note on Tuesday, September 16th. Barclays increased their price target on shares of Encompass Health from $141.00 to $150.00 and gave the company an “overweight” rating in a report on Thursday, October 30th. Finally, Bank of America boosted their price target on Encompass Health from $145.00 to $160.00 and gave the stock a “buy” rating in a research note on Wednesday, September 10th. Three investment analysts have rated the stock with a Strong Buy rating and eight have assigned a Buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus price target of $142.86.

Insider Activity at Encompass Health

In related news, EVP Patrick William Tuer sold 1,020 shares of the firm’s stock in a transaction on Wednesday, August 27th. The stock was sold at an average price of $123.59, for a total value of $126,061.80. Following the transaction, the executive vice president directly owned 18,846 shares of the company’s stock, valued at approximately $2,329,177.14. This trade represents a 5.13% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.00% of the stock is owned by company insiders.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.